CREATe Therapeutics

Our mission is to cure diseases via targets and mechanism of actions (MoAs) that cannot be reached with traditional approaches.

Using our unique ISEPTM and CREATeTM technologies, we optimize peptides and proteins of artificial and natural origin using directed evolution to create peptide-based pharmaceuticals or cutting-edge cell and gene therapy (CGT) products. The directed evolution platforms provide the very essence of our peptide/protein-based projects and enable us to handle a diverse portfolio, hence ensure the long-term stability of our R&D activities. Whereas on the fundamentally different parts of our projects, we cooperate with companies or academic laboratories having outstanding expertise on the subject.